LEADER 03528nam 22007693u 450 001 996339119103316 005 20230721033057.0 010 $a9781846952592 010 $a1-281-79090-7 010 $a9786611790905 010 $a1-84692-592-4 035 $a(CKB)1000000000549822 035 $a(EBL)362701 035 $a(OCoLC)437229076 035 $a(SSID)ssj0000258326 035 $a(PQKBManifestationID)12087005 035 $a(PQKBTitleCode)TC0000258326 035 $a(PQKBWorkID)10255332 035 $a(PQKB)10242898 035 $a(MiAaPQ)EBC362701 035 $a(EXLCZ)991000000000549822 100 $a20130418d2008|||| u|| | 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aTherapeutic Strategies for the Metabolic Syndrome$b[electronic resource] 210 $aOxford $cAtlas Medical Publishing Ltd$d2008 215 $a1 online resource (170 p.) 225 1 $aTherapeutic Strategies 300 $aDescription based upon print version of record. 311 $a1-904392-99-7 327 $aContents; Editor; Contributors; Preface; 1. Lifestyle intervention to reduce metabolic and cardiovascular risks; 2. Dietary controversies in treatment of the metabolic syndrome; 3. An exercise prescription for the metabolic syndrome; 4. Impact of hypoglycemic agents on the metabolic syndrome; 5. Weight loss agents and the metabolic syndrome; 6. Blockage of the renin-angiotensin system in metabolic syndrome: implications for the prevention of diabetes; 7. Lipid management in the metabolic syndrome; 8. A potential role for insulin in management of the metabolic syndrome 327 $a9. Suppressing inflammation: a novel approach to treating the metabolic syndrome10. GLP-1 analogues, DPP-IV inhibitors and the metabolic syndrome; List of Abbreviations; Index 330 $aThe metabolic syndrome is characterised by the presence in a particular individual of a number of metabolic risk factors that combine to put that patient at an increased risk of coronary artery disease, stroke, and diabetes. In this ground-breaking work, leading authorities in the field explain current thinking on how these risk factors may be managed, singly and in combination, enabling clinicians to formulate treatment plans that achieve better health outcomes for their patients. 410 0$aTherapeutic Strategies 606 $aMetabolic syndrome -- Chemotherapy 606 $aMetabolic syndrome -- Pathophysiology 606 $aMetabolic syndrome -- Treatment 606 $aMetabolic Syndrome X 606 $aInsulin Resistance 606 $aMetabolic Diseases 606 $aHyperinsulinism 606 $aNutritional and Metabolic Diseases 606 $aDiseases 606 $aGlucose Metabolism Disorders 615 4$aMetabolic syndrome -- Chemotherapy. 615 4$aMetabolic syndrome -- Pathophysiology. 615 4$aMetabolic syndrome -- Treatment. 615 2$aMetabolic Syndrome X 615 2$aInsulin Resistance 615 2$aMetabolic Diseases 615 2$aHyperinsulinism 615 2$aNutritional and Metabolic Diseases 615 2$aDiseases 615 2$aGlucose Metabolism Disorders 676 $a616.39 700 $aFonseca$b V$01013643 702 $aFonseca$b Vivian A 801 0$bAU-PeEL 801 1$bAU-PeEL 801 2$bAU-PeEL 906 $aBOOK 912 $a996339119103316 996 $aTherapeutic Strategies for the Metabolic Syndrome$92358147 997 $aUNISA